Announced Wed, 10 Jun · 17:27 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nikunj Mange & PACs

Promoter Stake BuyPromoter Below 50pctOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹120.60
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-2.5-2.5-0.7+1.2+3.0+6.9-21.3
Up moveDown movePending
AI summary

The promoter group of Aspira Pathlab & Diagnostics Ltd, led by Nikunj Velji Mange along with five PACs (Deepali, Raj, Jay, Arvind Karsandas, and Shraddha Bhanushali), acquired 22,82,507 equity shares representing 22.18% of the company's share capital through an open offer completed on 08/06/2026. Prior to this acquisition, the group's combined holding was 24,52,111 shares (23.82%), and after the acquisition it has risen to 47,34,618 shares (46.00%). The total equity share capital of the company stands at Rs. 10.29 crore divided into 1,02,93,000 equity shares of Rs. 10 each. This is part of a mandatory open offer triggered under SEBI Takeover Regulations, significantly increasing promoter control in the company.

Likely market impact

Promoter group holding has nearly doubled from 23.82% to 46.00%, signaling strong promoter commitment and tighter control over the company. While this is positive for governance stability, the acquirers remain just below the 50% threshold, meaning the company may still be vulnerable to further takeover activity.